THE HBF PILL
Live / Registered — Registered (as of 09 May 2023)
What this means for you
Registered since 09 May 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 May 2029: the §8 declaration of use).
Record
- Serial number
- 97264241
- Registration number
- 7050850
- Mark type
- Word mark
- Filed
- 11 Feb 2022
- Registered
- 09 May 2023
- Next maintenance filing
- §8 declaration of use, due by 09 May 2029 (grace period to 09 Nov 2029)
- Attorney of record
- Joshua S. Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of hematological rare and genetically defined diseases and disorders
Owner
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 05 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Feb 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 02 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 May 2023 — REGISTERED-SUPPLEMENTAL REGISTER
- 09 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Apr 2023 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 30 Mar 2023 — ASSIGNED TO LIE
- 17 Mar 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 16 Mar 2023 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER